TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
|
138
|
0 |
Financial expenses |
175
|
48
|
175 |
Earnings before taxes |
-17,074
|
-13,039
|
-14,521 |
EBITDA |
-17,036
|
-11,790
|
-12,467 |
Total assets |
426,333
|
377,166
|
327,856 |
Current assets |
46,677
|
85,373
|
76,098 |
Current liabilities |
13,796
|
17,899
|
11,298 |
Equity capital |
410,208
|
356,559
|
315,612 |
- share capital |
18,781
|
6,567
|
3,203 |
Employees (average) |
10
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.2%
|
94.5%
|
96.3% |
Turnover per employee |
0
|
17
|
0 |
Profit as a percentage of turnover | -9448.6% | ||
Return on assets (ROA) |
-4.0%
|
-3.4%
|
-4.4% |
Current ratio |
338.3%
|
477.0%
|
673.6% |
Return on equity (ROE) |
-4.2%
|
-3.7%
|
-4.6% |
Change turnover |
-139
|
138
|
-36,711 |
Change turnover % | -100% | -100% | |
Chg. No. of employees |
2
|
0
|
-3 |
Chg. No. of employees % |
25%
|
0%
|
-27% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.